Back to search
Meibomian Gland Dysfunction (MGD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Meibomian Gland Dysfunction (MGD) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Meibomian Gland Dysfunction (MGD) trials you may qualify forDry eye syndrome is a common eye disease that affects 1 to 2 out of 10 persons around the planet. One common cause of this disease is the meibomian gland dysfun…
The goal of this prospective, 24-week, double-masked, randomized, sham-controlled clinical trials to compare clinical efficacy and safety of RF and MGX with MGX…
The purpose of this research study is to understand the mechanism of action of low level light therapy and also potentially yield markers associated with good t…
TearCare is an office-based thermal therapeutic eyelid technology cleared by the US Food and Drug Administration for the treatment of evaporative dry eye diseas…
This research study evaluates a prescription eye drop called Vevye® (cyclosporine 0.1%) for adults who have meibomian gland dysfunction (MGD), a common eye cond…
Meibomian gland dysfunction (MGD), closely associated with Dry Eye Disease (DED), is a chronic condition where terminal ducts are obstructed and/or glandular se…